Preprint2022
The Pyroptosis-Related Signature Predicts Prognosis and Indicates New Treatment Targets in Pancreatic Cancer
- Published
- 13 May 2022
- Citations
- 0
- Type
- Preprint
- License
- cc by
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract cc by
Purpose: Pancreatic adenocarcinoma (PAAD) is a malignant tumor leading cause of cancer death worldwide. Pyroptosis is a recently identified inflammatory cell death that is associated with tumor progression, prognosis, and treatment response. Our study investigated the potential roles of pyroptosis-related genes (PRGs) in the tumor microenvironment (TME). Methods We explored 48 PRGs in 350 PAAD samples from genetic and transcriptional fields. Immunocyte subsets in three subgroups were investigated and we found that B-PRGcluster was correlated with PAAD progression and TME cell- infiltrating characteristics. Then, we established a highly accurate nomogram for improving the clinical applicability of the PRG_score. Moreover, we evaluated chemotherapeutic agents used for PAAD to assess the susceptibility of patients in low-risk and high-risk groups to these agents. Results Significant differences in the genetic landscape and expression levels of PRGs between PAAD and normal samples indicated a potential role for PRGs in the development of PAAD. The prognosis of PAAD patient was significantly correlated with the expression levels of PRG. The infiltration immune cells in B_PRGcluster was identified which play the role of PRG in the TME of PAAD. The PFS of 1,2 and 3 years had higher accuracy, and TP53 was the second most frequently mutated gene after KARS in high-risk and low-risk groups classified by PRG-score. The rise of Risk Score indicated that the number of patients in Dead state was significantly increased, and the gene expression showed a positive correlation with Risk Score. The correlation between Tumor Burden Mutation and risk score showed a significant positive correlation. Conclusion Our investigation of PRGs in PAAD revealed their potential roles in the TME, clinicopathological features, and prognosis. These findings highlight a new insight in the understanding of PRGs in PAAD and offer a novel approach to immunotherapy strategies.